FedEx (FDX) Getting Somewhat Positive News Coverage, Report Shows

Media coverage about FedEx (NYSE:FDX) has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. FedEx earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave media stories about the shipping service provider an impact score of 44.2847199066063 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Here are some of the news articles that may have effected Accern’s analysis:

How to Become a New Pot Stock Millionaire

Shares of FedEx stock traded down $6.79 during mid-day trading on Friday, reaching $229.48. 2,635,653 shares of the company’s stock were exchanged, compared to its average volume of 2,047,138. The firm has a market capitalization of $61,475.40, a PE ratio of 14.02, a P/E/G ratio of 1.19 and a beta of 1.32. The company has a current ratio of 1.43, a quick ratio of 1.50 and a debt-to-equity ratio of 0.85. FedEx has a 12-month low of $182.89 and a 12-month high of $274.66.

FedEx (NYSE:FDX) last announced its quarterly earnings results on Tuesday, March 20th. The shipping service provider reported $3.72 EPS for the quarter, beating analysts’ consensus estimates of $3.11 by $0.61. The firm had revenue of $16.53 billion during the quarter, compared to analysts’ expectations of $16.17 billion. FedEx had a net margin of 6.99% and a return on equity of 21.65%. The company’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same quarter last year, the company posted $2.35 earnings per share. research analysts expect that FedEx will post 15.14 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Stockholders of record on Monday, March 12th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Friday, March 9th. FedEx’s dividend payout ratio is presently 12.22%.

A number of research analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of FedEx from a “buy” rating to a “hold” rating in a research report on Friday. Stephens set a $306.00 target price on shares of FedEx and gave the company a “buy” rating in a research report on Wednesday. Morgan Stanley decreased their target price on shares of FedEx from $250.00 to $240.00 and set an “equal weight” rating for the company in a research report on Wednesday. Credit Suisse Group decreased their target price on shares of FedEx from $314.00 to $306.00 and set an “outperform” rating for the company in a research report on Wednesday. Finally, KeyCorp raised their target price on shares of FedEx from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Wednesday. One analyst has rated the stock with a sell rating, three have issued a hold rating and twenty-three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $279.66.

In other news, Director David P. Steiner sold 3,016 shares of the firm’s stock in a transaction dated Friday, January 5th. The shares were sold at an average price of $266.05, for a total transaction of $802,406.80. Following the completion of the sale, the director now owns 16,040 shares in the company, valued at approximately $4,267,442. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, COO David J. Bronczek sold 46,555 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $255.49, for a total transaction of $11,894,336.95. Following the sale, the chief operating officer now owns 48,562 shares of the company’s stock, valued at approximately $12,407,105.38. The disclosure for this sale can be found here. Company insiders own 8.45% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “FedEx (FDX) Getting Somewhat Positive News Coverage, Report Shows” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3300416/fedex-fdx-getting-somewhat-positive-news-coverage-report-shows.html.

About FedEx

FedEx Corporation (FedEx) provides a portfolio of transportation, e-commerce and business services through companies competing collectively, operating independently and managed collaboratively, under the FedEx brand. The Company’s segments include FedEx Express, TNT Express, FedEx Ground, FedEx Freight and FedEx Services.

Insider Buying and Selling by Quarter for FedEx (NYSE:FDX)

Receive News & Ratings for FedEx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FedEx and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Companhia de Saneamento Basico  and The Competition Financial Contrast
Companhia de Saneamento Basico and The Competition Financial Contrast
Contrasting Transcat  and Aehr Test Systems
Contrasting Transcat and Aehr Test Systems
Zacks: Brokerages Expect Karyopharm Therapeutics  to Announce -$0.67 EPS
Zacks: Brokerages Expect Karyopharm Therapeutics to Announce -$0.67 EPS
Hasbro  Given Consensus Rating of “Hold” by Analysts
Hasbro Given Consensus Rating of “Hold” by Analysts
Electronics for Imaging  Receives Average Recommendation of “Hold” from Analysts
Electronics for Imaging Receives Average Recommendation of “Hold” from Analysts
Medifast  Sets New 12-Month High and Low at $101.92
Medifast Sets New 12-Month High and Low at $101.92


© 2006-2018 Ticker Report. Google+.